Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,277.00 JPY | +0.24% |
|
-1.00% | -5.56% |
Feb. 04 | Mitsui Chemicals Inc- Commencing Tender Offer For DNA Chip Research | RE |
Feb. 03 | Mitsui Chemicals, Inc., Q3 2025 Earnings Call, Feb 04, 2025 |
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash And Equivalents | 149B | 196B | 181B | 186B | 210B | |||||
Total Cash And Short Term Investments | 149B | 196B | 181B | 186B | 210B | |||||
Accounts Receivable, Total | 272B | 286B | 370B | 352B | 366B | |||||
Other Receivables | 55.96B | 2.31B | 13.21B | 17.56B | 15.48B | |||||
Total Receivables | 328B | 288B | 384B | 370B | 381B | |||||
Inventory | 288B | 259B | 369B | 442B | 451B | |||||
Prepaid Expenses | - | 5.04B | 5.96B | 6.27B | 6.2B | |||||
Deferred Tax Assets Current | - | - | - | - | - | |||||
Other Current Assets, Total | 16.21B | 39.58B | 93.69B | 90.01B | 102B | |||||
Total Current Assets | 781B | 788B | 1,033B | 1,094B | 1,151B | |||||
Net Property Plant And Equipment | 486B | 502B | 554B | 601B | 652B | |||||
Long-term Investments | 173B | 238B | 276B | 295B | 332B | |||||
Goodwill | 4.41B | 1.12B | 17.98B | 19.34B | 21.17B | |||||
Other Intangibles, Total | 24.53B | 19.68B | 45.34B | 48.14B | 55.24B | |||||
Deferred Tax Assets Long-Term | 11.61B | 9.33B | 8.58B | 10.27B | 5.04B | |||||
Total Assets | 1,480B | 1,558B | 1,935B | 2,068B | 2,216B | |||||
Liabilities | ||||||||||
Accounts Payable, Total | 128B | 120B | 175B | 164B | 180B | |||||
Accrued Expenses, Total | 241M | - | - | - | - | |||||
Short-term Borrowings | 166B | 162B | 297B | 324B | 290B | |||||
Current Portion of Long-Term Debt | 52.61B | 54.54B | 49.18B | 44.34B | 34.46B | |||||
Current Income Taxes Payable | 83.55B | 6.2B | 12.9B | 7.42B | 4.04B | |||||
Other Current Liabilities | 47.6B | 123B | 172B | 155B | 153B | |||||
Total Current Liabilities | 478B | 466B | 707B | 695B | 661B | |||||
Long-Term Debt | 310B | 293B | 319B | 370B | 433B | |||||
Long-Term Leases | 22.56B | - | - | - | - | |||||
Pension & Other Post Retirement Benefits | 26.61B | 16.38B | 18.86B | 20.24B | 17.88B | |||||
Deferred Tax Liability Non Current | 14.55B | 27.83B | 28.13B | 35.16B | 42.14B | |||||
Other Non Current Liabilities | 20.03B | 72.49B | 54.81B | 64.27B | 77.11B | |||||
Total Liabilities | 872B | 876B | 1,128B | 1,185B | 1,231B | |||||
Common Stock, Total | 125B | 125B | 125B | 126B | 126B | |||||
Additional Paid In Capital | 89.51B | 74.01B | 69.87B | 57.78B | 55.03B | |||||
Retained Earnings | 366B | 424B | 516B | 575B | 617B | |||||
Treasury Stock | -39.25B | -24.9B | -34.93B | -32.7B | -32.75B | |||||
Comprehensive Income and Other | -14.3B | 9.4B | 36.21B | 61.06B | 97.44B | |||||
Total Common Equity | 528B | 608B | 713B | 787B | 863B | |||||
Minority Interest | 80.43B | 74.24B | 94.47B | 96.48B | 122B | |||||
Total Equity | 608B | 682B | 807B | 883B | 985B | |||||
Total Liabilities And Equity | 1,480B | 1,558B | 1,935B | 2,068B | 2,216B | |||||
Supplemental Items | ||||||||||
ECS Total Shares Outstanding on Filing Date | 191M | 196M | 193M | 190M | 190M | |||||
ECS Total Common Shares Outstanding | 191M | 196M | 193M | 190M | 190M | |||||
Book Value / Share | 2.76K | 3.1K | 3.69K | 4.14K | 4.54K | |||||
Tangible Book Value | 499B | 587B | 649B | 719B | 786B | |||||
Tangible Book Value Per Share | 2.61K | 3K | 3.36K | 3.78K | 4.14K | |||||
Total Debt | 551B | 510B | 666B | 738B | 757B | |||||
Net Debt | 402B | 314B | 485B | 552B | 546B | |||||
Debt Equivalent of Unfunded Proj. Benefit Obligation | -9.73B | -38.68B | -41.89B | -40.79B | -64.9B | |||||
Minority Interest, Total (Incl. Fin. Div) | 80.43B | 74.24B | 94.47B | 96.48B | 122B | |||||
Equity Method Investments, Total | - | 97.51B | 133B | 149B | 156B | |||||
Inventories - Raw Materials, Total | 84.71B | 82.82B | 116B | 132B | 132B | |||||
Inventories - Work In Process, Total | 7.86B | 7.48B | 9.41B | 11.67B | 10.47B | |||||
Inventories - Finished Goods, Total | 195B | 169B | 244B | 298B | 308B | |||||
Full Time Employees | 17.98K | 18.05K | 18.78K | 18.93K | 19.86K | |||||
Accumulated Allowance for Doubtful Accounts (Supple) | 3.51B | 1.46B | 1.26B | 1.19B | 1.12B |